← Leaderboards
Abby H Shevitz
Tufts Medical Center
$1,805,817
Attributed
$1,805,817
Total exposure
7
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,805,817 · 7
By mechanism
P01$1,262,251 · 1
M01$442,163 · 5
P51$101,403 · 1
Top collaborators
No co-investigators on record.
Most similar at Tufts Medical Center
Same institution · by research overlap
- Sherwood L Gorbach$12,233,213
- Andrew S Greenberg$10,129,433
- Ernst John Schaefer$8,539,085
- Christine A Wanke$18,324,933
- Orlando M Gutierrez$29,690,151
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsClinical ResearchHuman SubjectInsulin Sensitivity /ResistanceMetforminAids TherapyBody CompositionAntiaids AgentNutrient Intake ActivityAdipose TissueNutrition Related TagQuality Of LifeMetabolism DisorderBlood GlucoseEndocrine Gland /SystemBlood ChemistryPathologic ProcessDisease /Disorder Proneness /RiskDietary LipidDiabetes Mellitus GeneticsBlood LipidCortisolFamily GeneticsGlucose Tolerance Test
Grant awards (17)
EXERCISE INTERVENTIONS IN HIV INFECTED-ADULTS$129,831
M01 · FY2005 · RR
A COHORT STUDY OF HIV LIPODYSTROPHY$43,928
M01 · FY2005 · RR
ABS - 2 STUDY$19,525
M01 · FY2005 · RR
Exercise Interventions in HIV Infected-Adults$201,178
M01 · FY2004 · RR
A Cohort Study of HIV Lipodystrophy$46,665
M01 · FY2004 · RR
Alteration in Body Shape (ABS Study)$1,036
M01 · FY2004 · RR
THE METABOLIC EFFECTS OF ANTI-HIV THERAPY IN MACAQUES$101,403
P51 · FY2003 · RR
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$196,218
P01 · FY2002 · DK
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$196,218
P01 · FY2002 · DK
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$196,218
P01 · FY2002 · DK
Metformin hydrochloride in lipodystrophy in HIV positive patients$0
M01 · FY2002 · RR
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$196,218
P01 · FY2001 · DK
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$161,817
P01 · FY2001 · DK
Metformin hydrochloride in lipodystrophy in HIV positive patients$0
M01 · FY2001 · RR
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$161,817
P01 · FY2000 · DK
FAT REDISTRIBUTION AND METABOLIC ABNORMALITIES$153,745
P01 · FY2000 · DK
Metformin hydrochloride in lipodystrophy in HIV positive patients$0
M01 · FY2000 · RR